Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 16671-16680 Newer>

The Motley Fool September 5, 2006 Alyce Lomax	A Big Eye on TiVo TiVo may soon bring time shifting to a whole new level, judging by its deal with CBS. Investors who have been watching TiVo know that this is just the latest in some pretty impressive agreements it has been racking up.
The Motley Fool September 5, 2006 Brian Lawler	Adolor: Positive Results, Negative Reaction The market seems confused by good results from Adolor's latest clinical trial. Investors willing to take a gamble on Adolor at this price may be in for huge rewards if the company and Glaxo can convince the FDA of Entereg's viability.
The Motley Fool September 5, 2006 Rich Smith	Foolish Forecast: Natuzzi Not Napping The Italian sofa maker reports second-quarter 2006 earnings results. Investors, do you want to know what Wall Street expects to see? Do you want to know what really matters?
The Motley Fool September 5, 2006 Rich Smith	Foolish Forecast: Triggering Smith & Wesson The gun maker reports first-quarter 2007 earnings results tomorrow afternoon. Do you want to know what Wall Street expects to see? Do you want to know what really matters?
The Motley Fool September 5, 2006 Tim Beyers	A Sirius Threat to the iPod? Once rumored to be partners, the satellite radio rebel and the Mac maker square off. Investors, take note.
The Motley Fool September 5, 2006 Alyce Lomax	Caribou Stabs at Starbucks Investors and rivals alike are keeping a close eye on Starbucks these days. Caribou, a much smaller competitor, announced an aggressive jab last week, hoping to benefit from a recent Starbucks misstep.
The Motley Fool September 5, 2006 Jack Uldrich	Competitors Look to Take a Bite out of Apple Three new music downloading initiatives could threaten iTunes' dominance. Apple, which now generates 45% of its revenue from its iPod/iTunes division, and its investors could find themselves between a rock and a hard place.
The Motley Fool September 5, 2006 Brian Lawler	Neurocrine Wakes Up Indiplon The biotech company announces new drug delays. Investors, take note.
The Motley Fool September 5, 2006 Rick Aristotle Munarriz	Viacom Is on the Move There's plenty going on at the media giant, and not all of it is welcome. Investors, take note.
The Motley Fool September 5, 2006 Rich Smith	Embraer Ascendant Heading into the Labor Day weekend, investors decided to do a lot of their back-to-school shopping on the NYSE this year, buying shares of Brazilian airplane maker Embraer hand over fist and sending the stock price up 9% by week's end.
<Older 16671-16680 Newer> Return to current articles.